Abacavir and lamivudine are antiretroviral agents. Both of these medicines are nucleoside reverse transcriptase inhibitors (NRTIs). The combination of abacavir and lamivudine is used for the treatment of HIV infections in combination with other antiretroviral agents.
| Reasons taken | # of patients | Major | Moderate | Slight | None | Can’t tell | # of patients evaluated by |
|---|---|---|---|---|---|---|---|
| Treat my HIV | 83 |
|
|
|
16 | ||
| Support another treatment | 3 |
|
2 | ||||
| Fatigue | 2 |
|
1 | ||||
| Night sweats | 1 | 0 | |||||
| Improve immune function | 1 |
|
1 | ||||
| treat HIV | 1 | 0 |
Mouse over the table for more information
Top 10 dosages based on patients currently taking Abacavir-Lamivudine. See all 12 dosages ►
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
|
Side effects too severe
|
6 | 40% |
|
|
Other
|
4 | 27% |
|
|
Doctor's advice
|
3 | 20% |
|
|
Personal research
|
2 | 13% |
|
|
Did not seem to work
|
1 | 7% |
|
|
Not indicated
|
1 | 7% |
|
See all 14 patients who’ve stopped taking Abacavir-Lamivudine
See more information, including instructions, precautions, side effects, and interactions.
Report created on November 21, 2009.